Core Capital Management & Research, inc.’s Zimmer Biomet ZBH Stock Holding History

Core Capital Management & Research, inc.’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$118K	Buy	+1,169	New	+$103K	0.06%	97

Other funds holding ZBH

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Core Capital Management & Research, inc.'s ZBH Position: Q2 2026 in Review

Core Capital Management & Research, inc. opened a new position in Zimmer Biomet (ZBH) in Q2 2026: 1,169 shares worth $118K. The stake represents 0.06% of the portfolio and ranks #97 among its holdings.

909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

Core Capital Management & Research, inc. held 1,169 shares of Zimmer Biomet worth $118K as of Q2 2026.
Zimmer Biomet was a new Core Capital Management & Research, inc. position in Q2 2026.
Zimmer Biomet made up 0.06% of Core Capital Management & Research, inc.'s portfolio in Q2 2026, its #97 holding.
909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Core Capital Management & Research, inc.'s 13F filing for Q2 2026, filed 9 Sep 2026.